Surgery Partners, Inc. (NASDAQ: SGRY) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $3.5B. The Maz Rating grades it against the other companies in its sector.
Surgery Partners, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $26.85, Surgery Partners, Inc. trades at 1.0x sales and 2.1x book value, with an EV/EBITDA of 9.7. Over the last twelve months it generated about $3.4B of revenue and a net loss of $88M. It runs a gross margin of 21.1%, an operating margin of 11.3% and a net margin of -2.6%. It shows return on equity of -5.2%, return on invested capital of 4.5% and a free cash flow yield of 5.8%. On the balance sheet: a debt-to-equity ratio of 1.99 and a current ratio of 2.17. Over the past 52 weeks the share price ranged from $11.41 to $27.23, with a beta of 1.88.
Surgery Partners, Inc. does not currently pay a dividend.
23 Wall Street analyst ratings cover the stock: 11 Buy and 12 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, Surgery Partners, Inc. (SGRY) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 140.3% / 30% · (Cash+Inv) / Mkt Cap (36m) 26.6% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 140.3% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 16.3% / 33% · Receivables / Mkt Cap (36m) 21.5% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 140.3% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 16.3% / 33.33% · Receivables / Mkt Cap (24m) 21.5% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 42.8% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 3.18% / 33.33% · Receivables / Avg Assets (4Q) 7.33% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 43.3% / 33.33% · (Cash+ST Inv) / Total Assets 5.03% / 33.33% · (Cash+Recv) / Total Assets 11.7% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, Surgery Partners, Inc. (SGRY) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Surgery Partners, Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m).
Surgery Partners, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.